Breast Cancer Clinical Trial
Intensity Modulated Radiotherapy for Breast Cancer
Summary
This study delivers radiation therapy to any residual breast tissue and the chest wall plus lymph node areas around the breast. These lymph node areas are under the arm, around the collar bone, and under the sternum (breastbone).
Full Description
IMRT treatment uses a computer-controlled x-ray (CT) to deliver radiation beams at several different angles and strengths to deliver precise doses to the regions at risk for recurrence of breast cancer while reducing or sparing the dose to critical structures (heart, lungs) and nearby normal tissue.
Eligibility Criteria
Inclusion Criteria:
Female gender
Age ≥ 18 years
Invasive primary female breast cancer
Pathologically proven regional nodal metastasis
Status post mastectomy or partial mastectomy with an assessment of axillary nodes via sentinel lymph node biopsy and/or axillary lymph node dissection.
Signed study specific consent form
Exclusion Criteria:
Distant metastasis
Currently Pregnant
Psychiatric or addictive disorders that preclude informed consent
Time from initial diagnosis to the start of radiation therapy > one year
Estimated life expectancy judged to be < one year
Prior radiation to the ipsilateral breast or chest wall
Primary breast cancer is lymphoma or sarcoma
Patients being treated with concurrent chemotherapy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Saint Louis Missouri, 63110, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.